MedPath

Plasty or Prosthesis to Treat Functional Mitral Regurgitation

Not Applicable
Terminated
Conditions
Functional Mitral Regurgitation
Registration Number
NCT00947921
Lead Sponsor
Cardiochirurgia E.H.
Brief Summary

Functional Mitral regurgitation is a now well known entity due to tethering of the valve either mono-lateral, as happens in lateral myocardial infarction, or bilateral as happens in dilated cardiomyopathy. Treatment of this pathology, either conserving the valve and addressing regurgitation by mean of restrictive annuloplasty, or implanting a prosthesis remains controversial in terms of mid and long term benefit for the patient. The investigators propose a randomized controlled study to compare the efficacy of both technique in terms of mortality and freedom from reintervention.

Detailed Description

Not available

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
20
Inclusion Criteria
  • All patients presenting for surgery due to functional mitral regurgitation
Exclusion Criteria
  • Associated Heart Surgery procedures other than CABG, Tricuspid Regurgitation correction, Atrial Fibrillation Correction

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Mortality1 year of follow up after discharge from hospital
Secondary Outcome Measures
NameTimeMethod
Freedom from reintervention1 year of follow-up after discharge from hospital

Trial Locations

Locations (1)

Divisione di Cardiochirurgia, E.H.

🇮🇹

Rome, Italy

Divisione di Cardiochirurgia, E.H.
🇮🇹Rome, Italy

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.